Octapharma

FIBRYGA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Octapharma

Fibryga HCPCS:

J7177

HCPCS Code Descriptor:

Injection, human fibrinogen concentrate (fibryga), 1 mg

Category:

J Code

Fibryga NDCs:

68982-0347-01, 68982-0348-01

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Fibryga CPT Codes:

Potential CPT administration codes for Fibryga can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

68982-0348-01

About Fibryga:

FIBRYGA is a Hematology drug manufactured by Octapharma and administered via the Intravenous route of administration. The J Code: J7177 is aligned to the drug FIBRYGA.

FIBRYGA is concentrated human fibrinogen that may be used to treat acute bleeding in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia but not dysfibrinogenemia. Fibrinogen is a critical part of the coagulation cascade, acting as the precursor to fibrin, one of the elements of a functional blood clot in response to internal or external bleeding. FIBRYGA (J7177) supplements missing fibrinogen in patients with congenital fibrinogen deficiency. It is commonly used in adults and adolescents.

ACCESS PRICING AND MORE BY REGISTERING

J7177 Added Date:

January 1, 2019

J7177 Effective Date:

January 1, 2019

J7177 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Fibryga billing and coding information.
Fibryga patient assistance information can be found through Octapharma Patient Assistance at the URL: https://fibrygausa.com/fibryga-co-pay-assistance-program/#hcp
FIBRYGA prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for FIBRYGA. Please check back in a few weeks.